Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten offering of 3,000,000 shares of its common stock at an ...
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...
Bristol library staff threatened with shotgun and chased down street with machetes
Bristol library staff have been threatened with a shotgun, chased down the streets with machetes, subjected to physical ...